Periscope Capital’s Ibere Pharmaceuticals Warrants IBER.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding IBER.WS
Periscope Capital's IBER.WS Position: Q1 2023 in Review
Periscope Capital sold out of Ibere Pharmaceuticals Warrants (IBER.WS) in Q1 2023, closing a stake of 362,811 shares — an estimated $4.06K sold.
Periscope Capital first reported a position in IBER.WS in Q4 2021 and held it in 5 quarters. The position peaked at $67K in Q4 2021. 1 fund tracked by Wall St. Rank holds IBER.WS as of Q1 2023.
- Periscope Capital reported no remaining Ibere Pharmaceuticals Warrants position as of Q1 2023 after selling out during the quarter.
- Periscope Capital sold 362,811 Ibere Pharmaceuticals Warrants shares in Q1 2023, an estimated $4.06K.
- Periscope Capital first reported a position in Ibere Pharmaceuticals Warrants in Q4 2021 and held it in 5 quarters.
- Periscope Capital's Ibere Pharmaceuticals Warrants position peaked at $67K in Q4 2021.
- 1 fund tracked by Wall St. Rank held Ibere Pharmaceuticals Warrants as of Q1 2023.
Based on Periscope Capital's 13F filing for Q1 2023, filed 12 May 2023.